Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 3/20 | 0.36 |
| ▸ | HTR1A | P08908 | 3/20 | 0.34 |
| ▸ | HTR7 | P34969 | 3/20 | 0.34 |
| ▸ | EGFR | P00533 | 3/20 | 0.34 |
| ▸ | MET | P08581 | 2/20 | 0.34 |
| ▸ | INSR | P06213 | 1/20 | 0.34 |
| ▸ | FLT4 | P35916 | 2/20 | 0.33 |
| ▸ | PTK2 | Q05397 | 2/20 | 0.33 |
| ▸ | PLK1 | P53350 | 1/20 | 0.33 |
| ▸ | PCK1 | P35558 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 3/20 | 0.33 |
| ▸ | AXL | P30530 | 2/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24309559 | 1.00 | SCN9A (0.36) | SCN9AHTR1AHTR7EGFRMET | |
| SCHEMBL24309548 | 0.95 | SCN9A (0.34) | SCN9AHTR1AHTR7EGFRFLT4 | |
| SCHEMBL29566769 | 0.95 | SCN9A (0.34) | SCN9AHTR1AHTR7EGFRFLT4 | |
| SCHEMBL24309541 | 0.91 | HTR1A (0.34) | SCN9AHTR1AHTR7FLT4PTK2 | |
| SCHEMBL24310783 | 0.90 | SCN9A (0.40) | SCN9AHTR1AHTR7FLT4PTK2 | |
| SCHEMBL29567070 | 0.90 | SCN9A (0.40) | SCN9AHTR1AHTR7FLT4PTK2 | |
| SCHEMBL24309520 | 0.89 | SCN9A (0.35) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL29566590 | 0.89 | SCN9A (0.35) | SCN9AHTR1AHTR7PCK1BRD4 | |
| SCHEMBL24309558 | 0.88 | SCN9A (0.34) | SCN9AHTR1AHTR7PTK2PCK1 | |
| SCHEMBL24310541 | 0.88 | SCN9A (0.36) | SCN9AHTR1AHTR7EGFRMET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4225748-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |